Cargando…
Mucosal expression of PI3, ANXA1, and VDR discriminates Crohn’s disease from ulcerative colitis
Differential diagnosis of inflammatory bowel disease (IBD) to Crohn’s disease (CD) or ulcerative colitis (UC) is crucial for treatment decision making. With the aim of generating a clinically applicable molecular-based tool to classify IBD patients, we assessed whole transcriptome analysis on endosc...
Autores principales: | James, Jaslin Pallikkunnath, Nielsen, Boye Schnack, Christensen, Ib Jarle, Langholz, Ebbe, Malham, Mikkel, Poulsen, Tim Svenstrup, Holmstrøm, Kim, Riis, Lene Buhl, Høgdall, Estrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611705/ https://www.ncbi.nlm.nih.gov/pubmed/37891214 http://dx.doi.org/10.1038/s41598-023-45569-3 |
Ejemplares similares
-
MicroRNA Biomarkers in IBD—Differential Diagnosis and Prediction of Colitis-Associated Cancer
por: James, Jaslin P., et al.
Publicado: (2020) -
Mucosal microRNAs relate to age and severity of disease in ulcerative colitis
por: Malham, Mikkel, et al.
Publicado: (2021) -
miR-21 Expression in Cancer Cells may Not Predict Resistance to Adjuvant Trastuzumab in Primary Breast Cancer
por: Nielsen, Boye Schnack, et al.
Publicado: (2014) -
Potential Targeted Therapies in Ovarian Cancer
por: Sisman, Yagmur, et al.
Publicado: (2022) -
Organoids and epithelial ovarian cancer - a future tool for personalized treatment decisions? (Review)
por: Sisman, Yagmur, et al.
Publicado: (2022)